Eliquis Tablet, Film Coated
Product Images NDC 50090-1437

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Eliquis (NDC 50090-1437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Apixaban Chemical Structure (Apixaban Struct)

Chemical structure of apixaban, the active ingredient in ELIQUIS tablets. The diagram depicts the molecular components and their bonds in the apixaban molecule.*

FDA Label Image

Aristotle Forest Plot (Eliquis Clin Forest Fig5)

A forest plot comparing the hazard ratios of apixaban versus warfarin across various patient subgroups including prior Warfarin/VKA status, age, sex, weight, prior stroke or TIA, diabetes status, CHADS2 score, creatinine clearance levels, geographic region, and aspirin use at randomization. The plot shows hazard ratios with 95% confidence intervals indicating the relative effect of apixaban compared to warfarin.*

FDA Label Image

Aristotle Major Bleeding Forest Plot (Eliquis Forest Fig1)

A forest plot comparing the hazard ratios with 95% confidence intervals for various patient subgroups treated with apixaban versus warfarin. The plot includes subgroups by prior warfarin status, age, sex, weight, stroke history, diabetes status, CHADS2 score, creatinine clearance, geographic region, and aspirin use. The x-axis ranges from 0.125 to 2, indicating relative risk where values left of 1 favor apixaban and right favor warfarin.*

FDA Label Image

Aristotle Kaplan-meier Curve (Eliquis Km Fig4)

A Kaplan-Meier curve comparing the proportion of subjects with stroke/systemic embolism over 36 months between ELIQUIS (apixaban) and warfarin groups. The graph plots time in months on the x-axis and the proportion of subjects affected on the y-axis, with event counts and numbers at risk displayed for both treatments.*

FDA Label Image

Effects Of Drugs On Pk (Eliquis Pkplot Drugs Fig2)

A fold change graph showing the pharmacokinetic effects (Cmax and AUC) of various interacting drugs on apixaban. Drugs include ketoconazole, clarithromycin, diltiazem, naproxen, and rifampin, grouped as combined P-gp and strong CYP3A4 inhibitors, other CYP3A4 and P-gp inhibitors, and combined P-gp and strong CYP3A4 inducer. The x-axis shows change relative to reference from 0.5 to over 2.0 with 90% confidence intervals.*

FDA Label Image

O:\e-submissions\pbo\products\eliquis 202155\08. Pas Esrd Dosing\01. Orig Submission\source\eliquis-pkplot-pop-fig3.jpg (Eliquis Pkplot Pop Fig3)

A chart depicting the pharmacokinetic impact of various population characteristics on apixaban exposure, showing fold changes and 90% confidence intervals for Cmax and AUC relative to a reference. It summarizes dose adjustment recommendations for populations with different renal and hepatic impairments, ages, and body weights, indicating mostly no dose adjustment except where dosing recommendation cannot be provided.*

FDA Label Image

Label Image (Lbl500901436)

Label for ELIQUIS (apixaban) 2.5 mg film-coated tablets by A-S Medication Solutions. The label indicates a package size of 60 tablets, storage instructions to keep at 68 to 77 degrees Fahrenheit, and includes the product number 6513-0 along with a lot number and QR codes for dosage information. The route of administration is oral.*

FDA Label Image

Label Image (Lbl500901437)

The label for ELIQUIS 5 mg film-coated tablets by A-S Medication Solutions displays product information including the NDC number (50090-1437-0), product number (6514-0), and the active ingredient apixaban. It notes the storage temperature range of 68 to 77 degrees Fahrenheit and that the package contains 60 tablets. Additional details include a QR code, a barcode, and the distributor's address in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.